Literature DB >> 3049118

The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension.

N N Stanley1, J L Thirkettle, M P Varma, H Larkin, I D Heath.   

Abstract

In this randomized, double-blind, cross-over study we investigated the haemodynamic effects of a beta-blocker (atenolol 50 mg) and a calcium antagonist (nifedipine SR 20 mg) given either separately or in combination in three groups of hypertensive patients. Each treatment was administered twice daily. The fixed combination given twice daily for four weeks produced reductions in blood pressure which lasted for at least 12 h after administration of the last dose. The control of blood pressure by the combination was superior to that achieved by its individual components. Adverse effects normally associated with nifedipine were less frequent when it was given with atenolol. Compliance with treatment was good, but best when the drugs were given together rather than separately. A fixed combination of atenolol and nifedipine may prove useful in treating hypertensive patients inadequately controlled on beta-blocker therapy alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049118     DOI: 10.1007/BF00615215

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  To be taken as directed.

Authors:  M S Gatley
Journal:  J R Coll Gen Pract       Date:  1968-07

2.  The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1984-05

3.  Epinephrine-induced hypokalemia: the role of beta adrenoceptors.

Authors:  J L Reid; K F Whyte; A D Struthers
Journal:  Am J Cardiol       Date:  1986-04-25       Impact factor: 2.778

Review 4.  Nifedipine in combination therapy for chronic hypertension. A review.

Authors:  L G Ekelund
Journal:  Am J Med       Date:  1985-10-11       Impact factor: 4.965

5.  Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.

Authors:  R Fogari; A Zoppi
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-07

6.  Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  S E Husted; H K Nielsen; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol.

Authors:  L H Opie; L Jee; D White
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

8.  Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

9.  Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.

Authors:  A R Daniels; L H Opie
Journal:  Am J Cardiol       Date:  1986-04-15       Impact factor: 2.778

10.  The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.

Authors:  A D Struthers; J L Reid; R Whitesmith; J C Rodger
Journal:  Clin Sci (Lond)       Date:  1983-08       Impact factor: 6.124

View more
  2 in total

Review 1.  [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].

Authors:  A Krivitzky; G Nguyen; Y Gaudouen; M Legrand; R Cohen
Journal:  Drugs       Date:  1998       Impact factor: 9.546

2.  Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.

Authors:  S H Thomas
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.